Literature DB >> 25031394

Inhibitory interneuron progenitor transplantation restores normal learning and memory in ApoE4 knock-in mice without or with Aβ accumulation.

Leslie M Tong1, Biljana Djukic2, Christine Arnold3, Anna K Gillespie1, Seo Yeon Yoon4, Max M Wang4, Olivia Zhang4, Johanna Knoferle2, John L R Rubenstein5, Arturo Alvarez-Buylla6, Yadong Huang7.   

Abstract

Excitatory and inhibitory balance of neuronal network activity is essential for normal brain function and may be of particular importance to memory. Apolipoprotein (apo) E4 and amyloid-β (Aβ) peptides, two major players in Alzheimer's disease (AD), cause inhibitory interneuron impairments and aberrant neuronal activity in the hippocampal dentate gyrus in AD-related mouse models and humans, leading to learning and memory deficits. To determine whether replacing the lost or impaired interneurons rescues neuronal signaling and behavioral deficits, we transplanted embryonic interneuron progenitors into the hippocampal hilus of aged apoE4 knock-in mice without or with Aβ accumulation. In both conditions, the transplanted cells developed into mature interneurons, functionally integrated into the hippocampal circuitry, and restored normal learning and memory. Thus, restricted hilar transplantation of inhibitory interneurons restores normal cognitive function in two widely used AD-related mouse models, highlighting the importance of interneuron impairments in AD pathogenesis and the potential of cell replacement therapy for AD. More broadly, it demonstrates that excitatory and inhibitory balance are crucial for learning and memory, and suggests an avenue for investigating the processes of learning and memory and their alterations in healthy aging and diseases.
Copyright © 2014 the authors 0270-6474/14/349506-10$15.00/0.

Entities:  

Keywords:  Alzheimer's disease; MGE-derived GABAergic progenitor; apoE; apoE knock-in mice; cell transplantation; learning and memory

Mesh:

Substances:

Year:  2014        PMID: 25031394      PMCID: PMC4099537          DOI: 10.1523/JNEUROSCI.0693-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice.

Authors:  H Hamanaka; Y Katoh-Fukui; K Suzuki; M Kobayashi; R Suzuki; Y Motegi; Y Nakahara; A Takeshita; M Kawai; K Ishiguro; M Yokoyama; S C Fujita
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

2.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

3.  Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology.

Authors:  R Seidl; N Cairns; N Singewald; S T Kaehler; G Lubec
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-02       Impact factor: 3.000

4.  Young neurons from medial ganglionic eminence disperse in adult and embryonic brain.

Authors:  H Wichterle; J M Garcia-Verdugo; D G Herrera; A Alvarez-Buylla
Journal:  Nat Neurosci       Date:  1999-05       Impact factor: 24.884

5.  Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele.

Authors:  D Grouselle; R Winsky-Sommerer; J P David; A Delacourte; P Dournaud; J Epelbaum
Journal:  Neurosci Lett       Date:  1998-10-09       Impact factor: 3.046

6.  Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.

Authors:  R Zimmer; A W Teelken; W B Trieling; W Weber; T Weihmayr; H Lauter
Journal:  Arch Neurol       Date:  1984-06

7.  Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications?

Authors:  S R Bareggi; M Franceschi; L Bonini; L Zecca; S Smirne
Journal:  Arch Neurol       Date:  1982-11

8.  A disorder of cortical GABAergic innervation in Alzheimer's disease.

Authors:  J Hardy; R Cowburn; A Barton; G Reynolds; P Dodd; P Wester; A M O'Carroll; E Lofdahl; B Winblad
Journal:  Neurosci Lett       Date:  1987-01-14       Impact factor: 3.046

9.  Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.

Authors:  P Davies; R Katzman; R D Terry
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

10.  GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior.

Authors:  Robert F Hunt; Kelly M Girskis; John L Rubenstein; Arturo Alvarez-Buylla; Scott C Baraban
Journal:  Nat Neurosci       Date:  2013-05-05       Impact factor: 24.884

View more
  50 in total

Review 1.  Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.

Authors:  Ashok K Shetty; Adrian Bates
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

2.  Interneuron Origins in the Embryonic Porcine Medial Ganglionic Eminence.

Authors:  Mariana L Casalia; Tina Li; Harrison Ramsay; Pablo J Ross; Mercedes F Paredes; Scott C Baraban
Journal:  J Neurosci       Date:  2021-02-26       Impact factor: 6.167

3.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

Review 4.  Epileptic activity in Alzheimer's disease: causes and clinical relevance.

Authors:  Keith A Vossel; Maria C Tartaglia; Haakon B Nygaard; Adam Z Zeman; Bruce L Miller
Journal:  Lancet Neurol       Date:  2017-04       Impact factor: 44.182

5.  Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice.

Authors:  Johanna Knoferle; Seo Yeon Yoon; David Walker; Laura Leung; Anna K Gillespie; Leslie M Tong; Nga Bien-Ly; Yadong Huang
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

Review 6.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

7.  Apolipoprotein E4 Causes Age-Dependent Disruption of Slow Gamma Oscillations during Hippocampal Sharp-Wave Ripples.

Authors:  Anna K Gillespie; Emily A Jones; Yuan-Hung Lin; Mattias P Karlsson; Kenneth Kay; Seo Yeon Yoon; Leslie M Tong; Philip Nova; Jessie S Carr; Loren M Frank; Yadong Huang
Journal:  Neuron       Date:  2016-05-05       Impact factor: 17.173

8.  Synaptic integration of transplanted interneuron progenitor cells into native cortical networks.

Authors:  MacKenzie A Howard; Scott C Baraban
Journal:  J Neurophysiol       Date:  2016-05-25       Impact factor: 2.714

9.  Synaptic Adhesion Molecule Pcdh-γC5 Mediates Synaptic Dysfunction in Alzheimer's Disease.

Authors:  Yanfang Li; Zhicai Chen; Yue Gao; Gaojie Pan; Honghua Zheng; Yunwu Zhang; Huaxi Xu; Guojun Bu; Hui Zheng
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

10.  Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer's Disease.

Authors:  Magdalena Martinez-Losa; Tara E Tracy; Keran Ma; Laure Verret; Alexandra Clemente-Perez; Abdullah S Khan; Inma Cobos; Kaitlyn Ho; Li Gan; Lennart Mucke; Manuel Alvarez-Dolado; Jorge J Palop
Journal:  Neuron       Date:  2018-03-15       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.